TAKE Solutions Limited Stock Bombay S.E.

Equities

TAKE

INE142I01023

Biotechnology & Medical Research

Market Closed - Bombay S.E. 06:00:50 2024-04-19 am EDT 5-day change 1st Jan Change
21.9 INR -0.59% Intraday chart for TAKE Solutions Limited -5.03% -5.03%
Sales 2022 6.55B 78.62M Sales 2023 1.89B 22.69M Capitalization 1.97B 23.69M
Net income 2022 -7.82B -93.88M Net income 2023 -1B -12.04M EV / Sales 2022 0.72 x
Net Debt 2022 489M 5.87M Net Debt 2023 356M 4.27M EV / Sales 2023 1.23 x
P/E ratio 2022
-0.54 x
P/E ratio 2023
-1.97 x
Employees 903
Yield 2022 *
-
Yield 2023
-
Free-Float 46.46%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.59%
1 week-5.03%
Current month+5.80%
1 month+2.77%
3 months-25.03%
6 months+4.14%
Current year-5.03%
More quotes
1 week
21.60
Extreme 21.6
23.20
1 month
20.10
Extreme 20.1
25.05
Current year
20.10
Extreme 20.1
35.78
1 year
14.40
Extreme 14.4
35.78
3 years
12.70
Extreme 12.7
74.65
5 years
12.70
Extreme 12.7
159.30
10 years
12.70
Extreme 12.7
308.30
More quotes
Managers TitleAgeSince
Founder 60 00-12-19
Director of Finance/CFO - 22-12-29
Chief Operating Officer - 21-12-06
Members of the board TitleAgeSince
Director/Board Member - -
Founder 60 00-12-19
Director/Board Member - 99-12-31
More insiders
Date Price Change Volume
24-04-19 21.9 -0.59% 9 156
24-04-18 22.03 -0.50% 21,100
24-04-16 22.14 +0.91% 31,846
24-04-15 21.94 -4.02% 47,712
24-04-12 22.86 -0.87% 35,701

Delayed Quote Bombay S.E., April 19, 2024 at 06:00 am EDT

More quotes
TAKE Solutions Limited is an India-based company, which provides domain-intensive services as a full-service clinical research organization (CRO) supporting pharma, biotech, and devices companies across the world. The Company operates through two segments: Life Sciences and Supply Chain Management. It offers full-service clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. Its services spans from clinical trials to regulatory submissions to post-marketing safety. It provides services in life sciences sector across the spectrum of clinical, regulatory, safety and pharmacovigilance, networks, and consulting to deliver end-to-end solutions and services across processes, technology, and analytics to both domestic and global clients. It also provides information technology (IT) infrastructure and support, engineering, designing, and sourcing services. The Company operates in North America, Europe, Asia, and South America.
More about the company